中南米の研究所が開発した2028年までの検査市場予測 – 新型コロナウイルス感染症の影響と地域分析（臨床生化学、救命救急、血液学、微生物学、分子診断、免疫学、その他の検査タイプ）および用途（学術機関、臨床研究）別組織、病院検査室、専門診断センターなど）
市場紹介
臨床開発検査 (LDT) は、体外診断検査の一種であり、国内で設計および使用されます。一つの研究室。これらの検査は、人体解剖学から採取した標本から、タンパク質、グルコースやコレステロールなどの化合物、DNA などの広範な分析対象物質を推定または区別するために利用できます。研究室や薬局が正確でエラーのない分析を行うための自動体外診断 (IVD) 手法の拡大により、この増加が加速すると予想されます。
市場の概要とダイナミクス
中南米の研究所開発のテスト市場は米国に到達すると予想されています2021年の8億3,455万米ドルから2028年までに12億9,392万米ドル。 2021 年から 2028 年にかけて 6.5% の CAGR で成長すると推定されています。市場の成長を促進する主な要因は、がんや遺伝性疾患の発生率の増加と、研究室で開発された検査の製品発売数の増加です。しかし、規制情勢の変化が中南米の臨床開発検査市場の成長を妨げています。
がんは、世界中で主な死因の 1 つです。 WHO によると、2018 年の死亡原因はがんで約 960 万人でした。臨床診断は早期の兆候や危険因子の検出に役立ち、早期介入への道を開きます。研究室開発検査 (LDT) は、スクリーニングから特定の病気の予防、病気の発症時の早期診断に至るまで、診断の各段階に決定的な影響を与えます。たとえば、Oncotype DX 臨床検査は、化学療法が早期乳がん患者に利益をもたらすかどうかを判断するために使用されます。また、病気の再発の可能性を評価するのにも役立ちます。この検査は、乳がんの手術中に採取された小さな組織サンプルに対して行われます。さらに、遺伝性疾患の発生率の増加もLDTの需要を押し上げています。市場には遺伝子検査が存在しないため、多くの LDT が遺伝子検査に利用できます。分子病理学協会の 2018 年の評価によると、医療市場では約 70,000 件の遺伝子検査が利用可能であり、そのほとんどが LDT です。したがって、がんの発生率の上昇と早期診断の重要性に対する意識の高まりにより、LDT の採用が促進されています。また、LDT は研究室内で開発および使用されており、他の研究室や医療施設に配布または販売されることはありません。したがって、新しいLDTの開発と導入の頻度は高くなります。さらに、SARS-CoV-2 変異体の出現が増加していることにより、ウイルスゲノム全体にわたって変異を特定、追跡、追跡する必要性が浮き彫りになっています。したがって、がんや自己免疫疾患を検出するための LDT の開発に関する研究の増加が市場の成長を推進しています。
新型コロナウイルス?パンデミック19は、すでに過剰な負担と資金不足に陥っている中南米の公的医療制度にとって、重大な試練となっている。国営の病院や診療所は、ベクター媒介疾患、市中感染、高率の非感染性疾患 (NCD) の治療により、すでに過大なストレスにさらされています。汎米保健機構（PAHO）によると、この地域における新型コロナウイルス感染症（COVID-19）の発生以来、NCDsの予防と治療は重大な影響を受けている。さらに、中南米では国内総生産（GDP）と中央政府の医療費が先進国に比べて著しく低い。新型コロナウイルス感染症（COVID-19）症例の増加により、多くの慢性疾患の治療が著しく混乱し、その結果、この地域の市場成長が妨げられています。
主要な市場セグメント
中南米の研究所開発検査市場は、タイプ別に、臨床生化学、救急医療、血液学、微生物学、分子診断、免疫学、その他の検査タイプ。血液学分野は、凝固止血、ヘモグロビン検査、血球検査などに細分化されています。分子診断セグメントは、2021 年に最大の市場シェアを保持すると予想されます。ただし、血液学セグメントは、予測期間中に最も高い CAGR を記録すると予想されます。
南部および中部アメリカの研究所開発の検査市場は、用途別に学術機関、臨床研究機関、病院の研究所、専門診断センターなどに分類されています。病院検査部門は、2021 年に最大の市場シェアを保持すると予想されます。ただし、専門診断センター部門は、予測期間中に最も高い CAGR を記録すると予想されます。
レポートを購入する理由
- 今後数年間の中南米の研究所開発のテスト市場の詳細な傾向分析に基づいて、将来の投資分野を決定します。
- 支出上位国におけるさまざまな依存症治療薬分野の需要を促進する根本的な要因を深く理解し、提供される機会を特定する
- 需要促進要因、業界トレンド、最新の技術開発などの観点から、市場に関する知識を強化します。 >
- 中南米の研究所開発のテスト市場を推進する主要なチャネルを特定し、将来の機会を明確に把握します。それは分析に役立ち、収益の拡大につながります。
- 各国が実施している進行中のプログラムに焦点を当ててリソースを集中させる 北米の研究所が開発したテスト市場。
>南米中米研究所の開発検査市場セグメンテーション
タイプ別
- 臨床生化学
- 救命救急
- 血液学
- 凝固と止血、
- ヘモグロビン検査
- 血球計算検査
- その他
- 免疫学
- 微生物学
- 分子診断
- その他の検査タイプ
作成者:アプリケーション
- 学術機関
- 臨床研究機関
- 病院の研究室
- 専門診断センター
- その他
国別
- Bブラジル
- アルゼンチン
- 南部のその他の地域および中央アメリカ
会社概要
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- < span>ガーダントヘルス
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Laboratory Developed Test Market – By Type
1.3.2 South and Central America Laboratory Developed Test Market – By Application
1.3.3 South and Central America Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –South and Central America Analysis
6.1 South and Central America Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market –South and Central America Analysis
9.1 South and Central America: Laboratory Developed Test Market
9.1.1 Overview
9.1.2 South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.3 South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 South and Central America: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.4 South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5 South and Central America: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.5.1 Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 Brazil Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2.1 Brazil: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.1.3 Brazil Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Argentina Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2.1 Argentina: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.2.3 Argentina Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.5.3 Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Rest of South and Central America Laboratory Developed Test Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2.1 Rest of South and Central America: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.5.3.3 Rest of South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on South and Central America Laboratory Developed Test Market
10.1 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Guardant Health
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America Africa Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Laboratory Developed Test Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 14. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 15. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. South and Central America Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. South and Central America Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 8. South and Central America Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 10. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 22. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South and Central America: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. South and Central America Laboratory Developed Test Market Revenue and Forecast to 2028 (USD Million)
Figure 29. South and Central America: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 30. Brazil: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Argentina: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of South and Central America: Laboratory Developed Test Market– Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in South and Central America Market
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Guardant Health
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.